相似文献
1
COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
Indian Pediatr. 2021 Feb 15;58(2):195.
2
COVID-19 Vaccine in Children: Where Do We Stand?
Indian Pediatr. 2021 Feb 15;58(2):194-195. doi: 10.1007/s13312-021-2150-5.
3
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.
4
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
Lancet. 2021 Jun 12;397(10291):2248. doi: 10.1016/S0140-6736(21)00976-4.
5
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.
6
The Covid-19 Vaccine-Development Multiverse. Reply.
N Engl J Med. 2021 Feb 18;384(7):682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27.
7
Mandatory Coronavirus Disease 2019 Vaccine for Children?-Reply.
JAMA Pediatr. 2021 May 1;175(5):534. doi: 10.1001/jamapediatrics.2020.6013.
8
Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".
Appl Health Econ Health Policy. 2021 Jul;19(4):623-624. doi: 10.1007/s40258-021-00657-1. Epub 2021 May 11.
9
Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.
Euro Surveill. 2021 Sep;26(35). doi: 10.2807/1560-7917.ES.2021.26.35.2100832.
10
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
Lancet. 2021 May 22;397(10288):1883-1884. doi: 10.1016/S0140-6736(21)00894-1. Epub 2021 May 12.
Zotero 插件